Literature DB >> 22526976

Depression and anxiety disorders in children and adolescents with velo-cardio-facial syndrome (VCFS).

Alice Fabbro1, Eleonora Rizzi, Maude Schneider, Martin Debbane, Stephan Eliez.   

Abstract

Velo-cardio-facial syndrome (VCFS) is characterized by a high prevalence of depression and anxiety disorders in childhood and adolescence. These disorders are a source of great impairment in everyday functioning, as well as important risk factors for the emergence of later psychotic disorders. Impairment in daily and social functioning as well as loss of IQ throughout growth are also are well-established correlates of the VCFS. This study aimed to confirm the high prevalence of depression and anxiety disorders. The second objective was to ascertain the correlation between anxious and depressive symptoms and the decline in adaptive and cognitive functioning. A total of 73 children and adolescents with VCFS (mean age 11.9 years) underwent psychiatric evaluation. Subjects were further divided into four age groups: ages 6-9, 9-12, 12-15 and 15-18 years. Assessments measuring intelligence, anxious and depressive symptoms, and adaptation skills reported by parents were submitted to a subsample of 62 children (mean age 12.2 years); 62.2 % of the sample showed an anxiety disorder, specific phobia being the most represented at all ages. Lifetime depression concerned 27 % of the sample, peaking at age 12-15 years. Anxious and depressive symptoms and low IQ were significantly associated with low adaptive functioning. Anxiety and depression are common disorders in children and adolescents with VCFS and have a great impact on adaptive functioning. Clinicians should pay great attention to diagnosis and treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22526976     DOI: 10.1007/s00787-012-0273-x

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  31 in total

Review 1.  Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease.

Authors:  Anne S Bassett; Stephen W Scherer; Linda M Brzustowicz
Journal:  Am J Psychiatry       Date:  2010-05-03       Impact factor: 18.112

2.  Association of the PIK4CA schizophrenia-susceptibility gene in adults with the 22q11.2 deletion syndrome.

Authors:  Jacob A S Vorstman; Eva W Chow; Roel A Ophoff; Herman van Engeland; Frits A Beemer; René S Kahn; Richard J Sinke; Anne S Bassett
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-04-05       Impact factor: 3.568

3.  The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study.

Authors:  D Shaffer; P Fisher; M K Dulcan; M Davies; J Piacentini; M E Schwab-Stone; B B Lahey; K Bourdon; P S Jensen; H R Bird; G Canino; D A Regier
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-07       Impact factor: 8.829

4.  Velocardiofacial syndrome: are structural changes in the temporal and mesial temporal regions related to schizophrenia?

Authors:  S Eliez; C M Blasey; E J Schmitt; C D White; D Hu; A L Reiss
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

Review 5.  Velo-cardio-facial syndrome: a distinctive behavioral phenotype.

Authors:  R J Shprintzen
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2000

6.  Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?

Authors:  D F Papolos; G L Faedda; S Veit; R Goldberg; B Morrow; R Kucherlapati; R J Shprintzen
Journal:  Am J Psychiatry       Date:  1996-12       Impact factor: 18.112

7.  Affective disorders and other psychiatric diagnoses in children and adolescents with 22q11.2 Deletion Syndrome.

Authors:  Edith M Jolin; Ronald A Weller; Naushad R Jessani; Elaine H Zackai; Donna M McDonald-McGinn; Elizabeth B Weller
Journal:  J Affect Disord       Date:  2009-03-09       Impact factor: 4.839

8.  Adolescent depressed mood and young adult functioning: a longitudinal study.

Authors:  D Devine; T Kempton; R Forehand
Journal:  J Abnorm Child Psychol       Date:  1994-10

9.  Early risk factors and developmental pathways to chronic high inhibition and social anxiety disorder in adolescence.

Authors:  Marilyn J Essex; Marjorie H Klein; Marcia J Slattery; H Hill Goldsmith; Ned H Kalin
Journal:  Am J Psychiatry       Date:  2009-11-16       Impact factor: 18.112

Review 10.  Anxiety in a neglected population: prevalence of anxiety disorders in pre-adolescent children.

Authors:  Sam Cartwright-Hatton; Kirsten McNicol; Elizabeth Doubleday
Journal:  Clin Psychol Rev       Date:  2006-03-03
View more
  14 in total

Review 1.  Behavioral and Psychiatric Phenotypes in 22q11.2 Deletion Syndrome.

Authors:  Kerri L Tang; Kevin M Antshel; Wanda P Fremont; Wendy R Kates
Journal:  J Dev Behav Pediatr       Date:  2015-10       Impact factor: 2.225

2.  Working Memory Impairments in Chromosome 22q11.2 Deletion Syndrome: The Roles of Anxiety and Stress Physiology.

Authors:  Ashley F P Sanders; Diana A Hobbs; David D Stephenson; Robert D Laird; Elliott A Beaton
Journal:  J Autism Dev Disord       Date:  2017-04

3.  Subthreshold psychotic symptoms in 22q11.2 deletion syndrome.

Authors:  Sunny X Tang; James J Yi; Tyler M Moore; Monica E Calkins; Christian G Kohler; Daneen A Whinna; Margaret C Souders; Elaine H Zackai; Donna M McDonald-McGinn; Beverly S Emanuel; Warren B Bilker; Ruben C Gur; Raquel E Gur
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-06-19       Impact factor: 8.829

4.  Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated.

Authors:  S X Tang; J J Yi; M E Calkins; D A Whinna; C G Kohler; M C Souders; D M McDonald-McGinn; E H Zackai; B S Emanuel; R C Gur; R E Gur
Journal:  Psychol Med       Date:  2013-09-09       Impact factor: 7.723

5.  Neurocognitive development in 22q11.2 deletion syndrome: comparison with youth having developmental delay and medical comorbidities.

Authors:  R E Gur; J J Yi; D M McDonald-McGinn; S X Tang; M E Calkins; D Whinna; M C Souders; A Savitt; E H Zackai; P J Moberg; B S Emanuel; R C Gur
Journal:  Mol Psychiatry       Date:  2014-01-21       Impact factor: 15.992

6.  Facial emotion perception by intensity in children and adolescents with 22q11.2 deletion syndrome.

Authors:  Arnaud Leleu; Guillaume Saucourt; Caroline Rigard; Gabrielle Chesnoy; Jean-Yves Baudouin; Massimiliano Rossi; Patrick Edery; Nicolas Franck; Caroline Demily
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-07-07       Impact factor: 4.785

7.  Childhood Predictors of Young Adult Social Functioning in 22q11.2 Deletion Syndrome.

Authors:  Kayla E Wagner; Wendy R Kates; Wanda Fremont; Kevin M Antshel
Journal:  J Autism Dev Disord       Date:  2017-08

8.  Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis.

Authors:  Finale Doshi-Velez; Yaorong Ge; Isaac Kohane
Journal:  Pediatrics       Date:  2013-12-09       Impact factor: 7.124

9.  Contribution of congenital heart disease to neuropsychiatric outcome in school-age children with 22q11.2 deletion syndrome.

Authors:  James J Yi; Sunny X Tang; Donna M McDonald-McGinn; Monica E Calkins; Daneen A Whinna; Margaret C Souders; Elaine H Zackai; Elizabeth Goldmuntz; James W Gaynor; Ruben C Gur; Beverly S Emanuel; Raquel E Gur
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-11-22       Impact factor: 3.568

Review 10.  A cross-comparison of cognitive ability across 8 genomic disorders.

Authors:  Michael Mortillo; Jennifer G Mulle
Journal:  Curr Opin Genet Dev       Date:  2021-05-31       Impact factor: 4.665

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.